| Feature | SBP | Secondary Peritonitis (perforation) |
|---|---|---|
| Organisms | Monomicrobial (single enteric organism -E. coli, Klebsiella, strep) | Polymicrobial (multiple organisms including anaerobes) |
| Glucose | > 50 mg/dL | < 50 mg/dL |
| LDH | < serum LDH | > serum LDH |
| Protein | Low (< 1 g/dL) | Higher |
| Treatment | Antibiotics alone | Antibiotics + surgical source control (CT abdomen โ OR) |
| Component | Regimen | Notes |
|---|---|---|
| Antibiotics IMMEDIATE | Ceftriaxone 2g IV daily ร 5 days | Covers E. coli, Klebsiella, strep. If nosocomial SBP or recent FQ prophylaxis failure โ broaden to piperacillin-tazobactam or meropenem (resistance is higher). Narrow based on culture + sensitivity. |
| Albumin CRITICAL | 1.5 g/kg on day 1, then 1 g/kg on day 3 | SBP Albumin Trial, 1999: albumin with antibiotics in SBP reduced HRS from 33% to 10% and mortality from 29% to 10%. One of the most impactful interventions in hepatology. Do not skip this. |
| Indication | Regimen |
|---|---|
| Prior SBP episode (secondary prophylaxis) | Norfloxacin 400 mg daily (or ciprofloxacin 500 mg daily or TMP-SMX DS daily) -lifelong |
| Ascitic protein < 1.5 g/dL + advanced liver disease (Child-Pugh โฅ 9 with bilirubin โฅ 3 OR Cr โฅ 1.2 or Na โค 130 or BUN โฅ 25) | Norfloxacin 400 mg daily (or alternatives as above). Fernรกndez, 2007: primary prophylaxis in high-risk patients reduced SBP incidence and improved survival. |
| Acute GI hemorrhage (all cirrhotics) | Ceftriaxone 1g IV daily ร 7 days -reduces SBP, bacteremia, and mortality in acute variceal bleed Fernรกndez, 2006. |
Patient: 56M with alcoholic cirrhosis (Child-Pugh C), large-volume ascites. Presents with fever 38.9ยฐC, diffuse abdominal tenderness, worsening hepatic encephalopathy.
Key findings: Paracentesis: PMN 520/mmยณ (โฅ 250 = SBP). Gram stain: GNR. Ascitic fluid protein 0.8 g/dL. Cr 1.1 (baseline 0.9).
Management:
Teaching point: Albumin reduces HRS from 33% to 10% and mortality from 29% to 10%. This is one of the highest-impact interventions in hepatology, never skip the albumin.
Patient: 63F with NASH cirrhosis, admitted for variceal bleed 5 days ago. On norfloxacin prophylaxis. New fever 38.4ยฐC, increasing abdominal distension.
Key findings: Paracentesis: PMN 380. Gram stain: GPC in clusters. Already on FQ prophylaxis, likely resistant organism.
Management:
Teaching point: Nosocomial SBP and SBP in patients on FQ prophylaxis have higher rates of resistant organisms (including MRSA and ESBL). Broaden empiric coverage to piperacillin-tazobactam or meropenem.
Patient: 48M with cirrhosis, abdominal pain, fever. Paracentesis: PMN 1200, glucose 28 mg/dL, LDH 450 (above serum ULN), total protein 2.8 g/dL. Gram stain shows polymicrobial organisms.
Key findings: Runyon criteria for secondary peritonitis met: glucose < 50, LDH > ULN, protein > 1 g/dL, polymicrobial. This is NOT SBP, suspect bowel perforation.
Management:
Teaching point: Always check ascitic fluid glucose, LDH, and protein to differentiate SBP from secondary peritonitis. Polymicrobial gram stain, glucose < 50, LDH > ULN, and protein > 1 g/dL suggest secondary peritonitis requiring CT and surgical evaluation.
| Parameter | Frequency | Target / Action |
|---|---|---|
| Repeat paracentesis | At 48 hours | PMN should drop > 25% from baseline. If not improving โ suspect resistant organism, secondary peritonitis, or wrong diagnosis. Broaden antibiotics and get CT abdomen. |
| BMP / Creatinine | Daily | HRS surveillance. Rising Cr despite albumin = hepatorenal syndrome โ urgent nephrology + hepatology consult. Cr is the most important lab to trend. |
| Urine output | Strict I&Os | UOP < 0.5 mL/kg/hr or declining โ early sign of HRS. Correlate with Cr trend. |
| Mental status | q4โ8h | HE surveillance -SBP is the most common precipitant of hepatic encephalopathy. Worsening confusion โ start/escalate lactulose. |
| Blood cultures | At diagnosis, repeat if persistent fever | Guide antibiotic narrowing once sensitivity data available. |
| Vitals | q4h | Fever curve, hemodynamics. Persistent fever > 72h on appropriate antibiotics โ reconsider diagnosis. |
| Drug | Dose | Duration | Notes |
|---|---|---|---|
| Ceftriaxone (Rocephin) 1ST LINE | 2g IV daily | 5 days | Covers E. coli, Klebsiella, Strep. Start immediately once PMN โฅ 250. If nosocomial SBP or FQ prophylaxis failure โ broaden to piperacillin-tazobactam or meropenem. |
| Albumin CRITICAL | 1.5 g/kg on day 1 + 1 g/kg on day 3 | 2 doses | Reduces HRS from 33% to 10% and mortality from 29% to 10% SBP Albumin Trial, 1999. Do NOT skip this -one of the highest-impact interventions in hepatology. |
| PROPHYLAXIS (after acute treatment) | |||
| Norfloxacin | 400 mg PO daily | Lifelong (secondary prophylaxis) | First-line for secondary prophylaxis after first SBP episode. Also for primary prophylaxis if ascitic protein < 1.5 g/dL with renal/liver dysfunction. |
| TMP-SMX DS | 1 DS tablet PO daily | Lifelong | Alternative to norfloxacin for secondary prophylaxis. Equally effective. |
| Ceftriaxone (Rocephin) | 1g IV daily | 7 days | Acute GI hemorrhage prophylaxis in all cirrhotics -reduces SBP, bacteremia, and mortality during variceal bleed. |